$UHS

A hospital company brought in $4.7 billion in a quarter, but profit fell to $309 million.

Universal Health Services (UHS) reported $4.7B revenue for Q3 2026, but net income fell to $309M. Adjusted admissions rose for both acute care and behavioral health services. The company repurchased 1.35M shares at $144M. UHS also disclosed a tentative settlement for ongoing litigation related to Cumberland Hospital.

Original reporting
Published Oct 27, 2026, 8:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$UHS
Bearish
high confidence
Mentioned
$UHS
Relevance
8/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$UHSBearishMed
01

Why it matters

The earnings miss could trigger a sell‑off, but the company’s cash generation and buyback may cushion the move.

02

Market read

UHS earnings are a key data point for the health‑care sector and may influence related stocks and REITs.

03

What to watch

Strong cash flow from operations and ongoing stock repurchase program may provide support.

Relevance 8/10Novelty 8/10Timing: post‑release today

Background

Universal Health Services (UHS) is one of the largest U.S. hospital operators, regularly watched by health‑care investors.

Company-level read

Ticker impact

$UHSBearishHigh confidence
Context

Universal Health Services reported Q3 revenue of $4.7 billion and profit of $309 million, a decline from prior periods.

Expected impact

likely downside as investors price in lower profit

Evidence & confidence

Revenue growth was modest and profit fell, which typically weighs on the stock immediately after release.

Market effects

Healthcare services sector may see broader pressure if earnings miss signals demand or reimbursement issues.

U.S. hospital operators could face heightened scrutiny on Medicaid/Medicare reimbursement trends.

Limited; primarily affects U.S. hospital REIT and health‑care investors.

Counterpoint

If the settlement of the Cumberland litigation reduces future liabilities, the stock could rebound despite the earnings miss.

Key entities

  • Universal Health Services, Inc.

    U.S. hospital and health‑care services provider

Related articles

$UHSHigh

Universal Health Services falls 3% on legal settlement concerns

Universal Health Services (UHS) reported Q3 earnings of $5.22 per share, beating estimates by $0.02, with revenue up 5.3% YoY to $4.73B. Shares fell 3% after-hours due to legal settlement costs and Medicaid payment uncertainties. The quarter included a $26M charge for a tentative settlement in Cumberland Hospital litigation, partially offset by a $21M Medicaid payment benefit. UHS repurchased 1.35M shares at $242.1M.

$UHSHigh

UNIVERSAL HEALTH SERVICES INC (UHS): ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2026

UNIVERSAL HEALTH SERVICES INC (UHS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE October 27, 2026 CONTACT: Darren Lehrich Vice President-Investor Relations 610-382-3310 Darren.Lehrich@uhsinc.com UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2026 Consolida

$UHSHighAI 8/10

Universal Health Services (NYSE:UHS) posts Q3 2026 sales in line with estimates

Universal Health Services (UHS) reported Q3 2026 revenue of $4.73 billion, matching estimates and showing 5.3% year-on-year growth. Adjusted EPS beat estimates at $5.22, while adjusted EBITDA missed at $624.6 million. Operating margin declined to 9.6% from 11.6% year-on-year, but free cash flow margin improved to 8.9% from 3.4%. Same-store sales rose 4.7% year-on-year, up from 2% in the prior year quarter.